In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Amitriptylin neuraxpharm Drug Master File in Korea (Amitriptylin neuraxpharm KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Amitriptylin neuraxpharm. The MFDS reviews the Amitriptylin neuraxpharm KDMF as part of the drug registration process and uses the information provided in the Amitriptylin neuraxpharm KDMF to evaluate the safety and efficacy of the drug.
After submitting a Amitriptylin neuraxpharm KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Amitriptylin neuraxpharm API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Amitriptylin neuraxpharm suppliers with KDMF on PharmaCompass.